U.S. Sen. Jacky Rosen's (D-Nev.) bill, S. 2257, is aimed at boosting nonprofit drug companies' competitiveness.

Rosen Introduces Bill to Boost Nonprofit Drug Makers’ Competitiveness

U.S. Sen. Jacky Rosen (D-Nev.) has introduced legislation to help nonprofit drug companies compete in the market with their for-profit counterparts.

Rosen’s bill S. 2257, the Expanding Access to Affordable Prescription Drugs and Medical Devices Act, would make it simpler for nonprofit manufacturers to obtain tax-exempt status from the Internal Revenue Service. It would also create a low-interest loan program and a federal cooperative agreement funding program (the latter, a type of grant program in which the federal awarding agency collaborates with the grantee on the project). The loans could be up to $5 million per borrower. The grants would support bringing an eligible drug or medical device to market within five years.

Please Login or Become a Paid Subscriber to View this Content

If you are already a paid subscriber, please follow the steps below.
If you are not yet a paid subscriber, please Subscribe now.
For questions about subscriptions or technical assistance, please contact Reshma Eggleston at reshma.eggleston@340breport.com.
« Read Previous Read Next »
Generic selectors
Exact matches only
Search in title
Search in content